**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 7783-90-6 |Silver chloride | 99+% | 232-033-3 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XI
Risk Phrases: 37
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to respiratory system.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause mild skin irritation. May cause cyanosis of the
extremities.
Ingestion:
May cause irritation of the digestive tract. Ingestion of soluble
silver salts may cause argyria, characterized by permanent blue-gray
pigmentation of the skin, mucous membranes, and eyes. Ingestion of
silver compounds may cause abdominal pain, rigidity, convulsions and
shock.
Inhalation:
Causes respiratory tract irritation.
Chronic:
Chronic inhalation or ingestion of silver salts may cause argyria
characterized by a permanent blue-gray discoloration of the eyes,
skin, mucous membranes, and internal organs. This malady results
from the accumulation of silver in the body. Chronic overexposure to
silver compounds may cause argyria (a slate gray or bluish
discoloration of the skin and deep tissues due to the deposit of
insoluble albuminate of silver).
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Never give anything by mouth to an
unconscious person. Get medical aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid if cough or other symptoms appear. Do
NOT use mouth-to-mouth resuscitation.
Notes to Physician:
Antidote:
The use of a metal chelator should be determined only by qualified
medical personnel.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
Wear appropriate protective clothing to prevent contact with skin
and eyes. Wear a self-contained breathing apparatus (SCBA) to
prevent contact with thermal decomposition products.
Non-combustible, substance itself does not burn but may decompose
upon heating to produce irritating, corrosive and/or toxic fumes.
Extinguishing Media:
Substance is noncombustible; use agent most appropriate to
extinguish surrounding fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes,
skin, and clothing. Keep container tightly closed. Avoid ingestion
and inhalation.
Storage:
Keep away from sources of ignition. Do not store near combustible
materials. Store in a tightly closed container. Store in a cool,
dry, well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 7783-90-6:
Japan: (listed as silver compounds): 0.01 mg/m3 OEL (as Ag)
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: white
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 2822 deg F
Freezing/Melting Point: 851 deg F
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Slightly soluble in water.
Specific Gravity/Density: 5.56
Molecular Formula: AgCl
Molecular Weight: 143.3212
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials:
Ammonia, aluminum, bromine trifluoride, potassium sodium, and sodium
peroxide+ charcoal.
Hazardous Decomposition Products:
Chlorine, silver fumes.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 7783-90-6: VW3563000
LD50/LC50:
Not available.
Carcinogenicity:
Silver chloride -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 37 Irritating to respiratory system.
Safety Phrases:
WGK (Water Danger/Protection)
CAS# 7783-90-6: 1
Canada
CAS# 7783-90-6 is listed on Canada's DSL List.
CAS# 7783-90-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7783-90-6 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #4 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
N-Methyl-1-naphthalenemethylamine hydrochloride
| 65473-13-4 |
|
2-Chloroanthraquinone, 99%
| 131-09-9 |
|
1H-Benzimidazole-2-methanol, 97%
| 4856-97-7 |
|
3-Amino-2-naphthoic acid, tech. 85%
| 5959-52-4 |
|
Resorcinol, 90% (Titr.)
| 108-46-3 |
|
Riboflavin 98%
| 83-88-5 |
|
Rosin, gum
| 8050-09-7 |
|
Rubidium Chloride, 99+%
| 7791-11-9 |
|
Salicylaldehyde, 98%
| 90-02-8 |
|
Avidin (monomeric)-agarose
| 0-01-1 |
|
Methyl 2-Iodobenzoate, 99+%
| 610-97-9 |
|
NG-Nitro-L-arginine-methyl ester hydrochloride
| 51298-62-5 |
|
NG-Nitro-D-arginine-methyl ester hydrochloride
| 50912-92-0 |
|
Ethyl butyrate, 99%
| 105-54-4 |
|
2,4-Dimethyl-3-Ethylpyrrole, 96+% (GC)
| 517-22-6 |
|
Salicylic Acid, reagent ACS
| 69-72-7 |
|
Silver, Shot, 99.9999%, 1-3 mm
| 7440-22-4 |
|
3-Methyl-1H-pyrazole-1-carboxamide
| 873-50-7 |
|
Silver acetate, 90% (titr.)
| 563-63-3 |
|
Ammonium Pyrrolidine Dithiocarbamate
| 5103-42-4 |
|
7-Nitroindazole
| 2942-42-9 |
|
S-Nitroso-N-acetyl-D,L-penicillamine
| 0-01-1 |
|
Silver Chloride, 99+%
| 7783-90-6 |
|
Diethyldithiocarbamic acid, silver salt
| 1470-61-7 |
|
Silver Iodide, 99%
| 7783-96-2 |
|
DL-Mercaptosuccinic acid (pract), 98% (titr.)
| 70-49-5 |
|
S-Nitroso-L-glutathione
| 0-01-1 |
|
Odq, 98%
| 41443-28-1 |
|
PAPA NONOate
| 146672-58-4 |
|
PROLI/NO
| 0-01-1 |
|
PTIO
| 0-01-1 |
|
Glycine Methyl Ester Hydrochloride, 98%
| 5680-79-5 |
|
L-Sepiapterin
| 17094-01-8 |
|
Ammonium sulfate
| 7783-20-2 |
|
SIN-1 hydrochloride
| 16142-27-1 |
|
trans-2-Aminomethyl-1-cyclohexanol, 97%
| 5691-09-8 |
|
Brij 58
| 9004-95-9 |
|
Quinidine, anhydrous, 99+%
| 56-54-2 |
|
Silver nitrate, p.a.
| 7761-88-8 |
|
Thiophene, benzene free, 99.5%
| 110-02-1 |
|
Silver(i)oxide, p.a.
| 20667-12-3 |
|
Silver Sulfate, 10 g/lt Solution in Sulfuric Acid P.A.
| 7664-93-9 |
|
1H-Benzimidazole-2-ethanamine dihydrochloride, 97%
| 0-01-1 |
|
Sodium dispersion in toluene, 30 wt% < 0.1mm particle size
| 108-88-3 |
|
Spermine NONOate
| 0-01-1 |
|
(6R)-5,6,7,8-Tetrahydro-L-biopterin.dihydrochloride
| 69056-38-8 |
|
L-Thiocitrulline
| 156719-37-8 |
|
TRIM
| 25371-96-4 |
|
2-Chloro-3,5-Dinitrobenzoic Acid, 80%
| 2497-91-8 |
|
Dimethyl sulfite, 99%
| 616-42-2 |
|
|